Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Sorscher

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Case Reports in Oncology|September 5, 2017
Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain SignificanceSteven Sorscher, Shakti Ramkissoon
Journal of the Advanced Practitioner in Oncology|August 12, 2024
The Ethics of Genetic Testing for Inherited Cancer-Predisposing GenesSteven Sorscher, Alisha T Detroye
JCO Precision Oncology|February 17, 2022
First Case Report of a Dramatic Radiographic Response to a Checkpoint Inhibitor in a Patient With Proficient Mismatch Repair Gene Expressing Metastatic Colorectal CancerSteven Sorscher, Jamie Resnick, Michael Goodman
International Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2004
Urethral 'recurrence' found 14 years after radical cystectomySteven Sorscher, Rezwan Islam, Albert Mason
Breast Cancer Research and Treatment|February 11, 2020
The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1)Steven Sorscher, Katherine Ansley, Steven Douglas Delaney, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 11, 2023
Family Matters: Germline Testing in Thoracic CancersFeighanne Hathaway, Renato Martins, Steven Sorscher, et al.
American Journal of Clinical Oncology|December 17, 2015
Immunogenicity of Influenza Vaccination in Patients With CancerSaiama N Waqar, Leigh Boehmer, Daniel Morgensztern, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancerManik Amin, Monica Desai, Kathryn Trinkaus, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 25, 2015
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinomaMay Cho, Andrea Wang-Gillam, Robert Myerson, et al.
Investigational New Drugs|August 7, 2012
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinomaAndrea Wang-Gillam, Stacey Plambeck-Suess, Peter Goedegebuure, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Case Reports in Oncology|September 5, 2017
Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain SignificanceSteven Sorscher, Shakti Ramkissoon
Journal of the Advanced Practitioner in Oncology|August 12, 2024
The Ethics of Genetic Testing for Inherited Cancer-Predisposing GenesSteven Sorscher, Alisha T Detroye
JCO Precision Oncology|February 17, 2022
First Case Report of a Dramatic Radiographic Response to a Checkpoint Inhibitor in a Patient With Proficient Mismatch Repair Gene Expressing Metastatic Colorectal CancerSteven Sorscher, Jamie Resnick, Michael Goodman
International Journal of Urology : Official Journal of the Japanese Urological Association|July 10, 2004
Urethral 'recurrence' found 14 years after radical cystectomySteven Sorscher, Rezwan Islam, Albert Mason
Breast Cancer Research and Treatment|February 11, 2020
The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1)Steven Sorscher, Katherine Ansley, Steven Douglas Delaney, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 11, 2023
Family Matters: Germline Testing in Thoracic CancersFeighanne Hathaway, Renato Martins, Steven Sorscher, et al.
American Journal of Clinical Oncology|December 17, 2015
Immunogenicity of Influenza Vaccination in Patients With CancerSaiama N Waqar, Leigh Boehmer, Daniel Morgensztern, et al.
Journal of Gastrointestinal Oncology|June 12, 2019
Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancerManik Amin, Monica Desai, Kathryn Trinkaus, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 25, 2015
A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinomaMay Cho, Andrea Wang-Gillam, Robert Myerson, et al.
Investigational New Drugs|August 7, 2012
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinomaAndrea Wang-Gillam, Stacey Plambeck-Suess, Peter Goedegebuure, et al.
Pageof 4